Total Payments
$1.2M
2024 Payments
$240,089
Companies
68
Transactions
1,657
Medicare Patients
8,445
Medicare Billing
$525,455
Payment Breakdown by Category
Other$848,719 (70.7%)
Travel$163,668 (13.6%)
Consulting$149,656 (12.5%)
Food & Beverage$35,679 (3.0%)
Research$1,380 (0.1%)
Education$538.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $846,886 | 304 | 70.6% |
| Travel and Lodging | $163,668 | 388 | 13.6% |
| Consulting Fee | $149,656 | 55 | 12.5% |
| Food and Beverage | $35,679 | 885 | 3.0% |
| Unspecified | $1,380 | 7 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,200 | 1 | 0.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $600.00 | 1 | 0.1% |
| Education | $538.11 | 15 | 0.0% |
| Entertainment | $32.12 | 1 | 0.0% |
Payments by Type
General
$1.2M
1,650 transactions
Research
$1,380
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $431,693 | 597 | $0 (2024) |
| GENZYME CORPORATION | $203,666 | 143 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $160,392 | 172 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71,807 | 82 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $68,694 | 131 | $0 (2024) |
| Veran Medical Technologies, Inc. | $50,124 | 37 | $0 (2020) |
| Ethicon Inc. | $44,764 | 47 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $42,280 | 60 | $0 (2024) |
| Mylan Specialty L.P. | $18,349 | 30 | $0 (2024) |
| Pinnacle Biologics, Inc | $15,416 | 35 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240,089 | 304 | Regeneron Healthcare Solutions, Inc. ($62,076) |
| 2023 | $275,241 | 380 | GlaxoSmithKline, LLC. ($88,180) |
| 2022 | $265,557 | 314 | GlaxoSmithKline, LLC. ($105,745) |
| 2021 | $177,262 | 214 | GlaxoSmithKline, LLC. ($74,327) |
| 2020 | $88,128 | 85 | GlaxoSmithKline, LLC. ($55,518) |
| 2019 | $94,745 | 173 | GlaxoSmithKline, LLC. ($52,770) |
| 2018 | $43,338 | 118 | Veran Medical Technologies, Inc. ($19,399) |
| 2017 | $15,278 | 69 | Sunovion Pharmaceuticals Inc. ($8,925) |
All Payment Transactions
1,657 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,593.00 | General |
| Category: Immunology | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $39.77 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $500.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $322.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $242.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $45.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $25.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $104.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,485.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous SAR443765 in Adult Participants With Moderate to Severe Asthma | SANOFI US SERVICES INC. | $1,380 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,159 | 2,694 | $559,992 | $138,148 |
| 2022 | 22 | 1,785 | 2,116 | $397,743 | $108,762 |
| 2021 | 27 | 2,341 | 2,677 | $507,118 | $138,713 |
| 2020 | 31 | 2,160 | 2,645 | $468,084 | $139,832 |
Total Patients
8,445
Total Services
10,132
Medicare Billing
$525,455
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 366 | $78,221 | $33,473 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 215 | 358 | $36,940 | $26,182 | 70.9% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 81 | 84 | $43,932 | $10,578 | 24.1% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 68 | 74 | $63,640 | $8,908 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $12,920 | $5,680 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 39 | $10,178 | $5,250 | 51.6% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 57 | 61 | $12,444 | $4,546 | 36.5% |
| 31641 | Destruction of growth or narrowing of lung airway using an endoscope | Facility | 2023 | 16 | 22 | $19,822 | $4,339 | 21.9% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 78 | 83 | $12,533 | $4,290 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 69 | $12,488 | $4,135 | 33.1% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 89 | 95 | $58,805 | $4,034 | 6.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 41 | 41 | $5,765 | $4,018 | 69.7% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 18 | 18 | $10,386 | $2,686 | 25.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 302 | 309 | $12,360 | $2,379 | 19.2% |
| 31626 | Placement of radiation therapy markers into lung airways using an endoscope | Facility | 2023 | 29 | 29 | $15,747 | $2,202 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 20 | $3,062 | $2,145 | 70.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 38 | 41 | $2,788 | $1,996 | 71.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 232 | 238 | $8,806 | $1,584 | 18.0% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 16 | 18 | $8,892 | $1,367 | 15.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 131 | 132 | $4,884 | $1,187 | 24.3% |
| 31630 | Dilation of windpipe cartilage or treatment of broken windpipe cartilage using an endoscope | Facility | 2023 | 15 | 20 | $12,800 | $1,136 | 8.9% |
| 31632 | Biopsy of lobe of lung using an endoscope, each additional lobe | Facility | 2023 | 17 | 29 | $2,900 | $1,112 | 38.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 119 | 137 | $68,500 | $958.09 | 1.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 104 | 105 | $5,250 | $953.70 | 18.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 15 | $1,800 | $932.40 | 51.8% |
About Dr. Sandeep Bansal, MD
Dr. Sandeep Bansal, MD is a Internal Medicine healthcare provider based in Du Bois, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215105267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Bansal, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $240,089 received in 2024. These payments were reported across 1,657 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($846,886).
As a Medicare-enrolled provider, Bansal has provided services to 8,445 Medicare beneficiaries, totaling 10,132 services with total Medicare billing of $525,455. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Pulmonary Disease
- Location Du Bois, PA
- Active Since 02/12/2008
- Last Updated 07/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215105267
Products in Payments
- DUPIXENT (Biological) $362,570
- NUCALA (Biological) $212,997
- TRELEGY ELLIPTA (Drug) $97,408
- TEZSPIRE (Biological) $62,509
- OFEV (Drug) $51,905
- Monarch Platform (Device) $50,940
- Spin (Device) $50,124
- GLASSIA (Biological) $40,665
- AREXVY (Drug) $28,640
- AIRSUPRA (Drug) $19,047
- Photofrin (Drug) $15,416
- Accent Pacemaker (Device) $10,519
- Yupelri (Drug) $9,885
- UTIBRON (Drug) $8,883
- YUPELRI (Drug) $8,464
- GALAXY (Device) $7,567
- ANORO (Drug) $6,002
- MONARCH (Device) $5,576
- LONHALA MAGNAIR (Drug) $4,143
- Da Vinci Surgical System (Device) $3,244
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Du Bois
Steven Graeca, D.o, D.O
Internal Medicine — Payments: $6,359
Internal Medicine $6,359
Sarvesh Rajan, Md, MD
Internal Medicine — Payments: $5,074
Internal Medicine $5,074
Stephen Kruk, D.o, D.O
Internal Medicine — Payments: $3,541
Internal Medicine $3,541
Dr. Kathryn Graham, D.o, D.O
Internal Medicine — Payments: $839.04
Internal Medicine $839.04
Jennifer Colvin, Md, MD
Internal Medicine — Payments: $762.07
Internal Medicine $762.07
Cory Baldwin, Do, DO
Internal Medicine — Payments: $576.20
Internal Medicine $576.20